Acknowledgement
We appreciate Dr. W.T. Im's lab for providing ginsenosides Rh2 as a raw material for this study.
References
- Chen Y, Zhang Y, Song W, Zhang Y, Dong X, Tan M. 2019. Ginsenoside Rh2 inhibits migration of lung cancer cells under hypoxia via mir-491. Anticancer Agents Med. Chem. 19: 1633-1641. https://doi.org/10.2174/1871520619666190704165205
- Choi WY, Lim HW, Lim CJ. 2013. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J. Pharm. Pharmacol. 65:310-316. https://doi.org/10.1111/j.2042-7158.2012.01598.x
- Christensen LP. 2009. Ginsenosides: chemistry, biosynthesis, analysis, and potential health effects. Adv. Food Nutr. Res. 55:1-99.
- Fukami H, Ueda T, Matsuoka N. 2019. Pharmacokinetic study of compound K in Japanese subjects after ingestion of Panax ginseng fermented by Lactobacillus paracasei A221 reveals significant increase of absorption into blood. J. Med. Food 22:257-263. https://doi.org/10.1089/jmf.2018.4271
- Han S, Jeong AJ, Yang H, Kang KB, Lee H, Yi EH, Kim BH, Cho CH, Chung JW, Sung SH, Ye SK. 2016. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells. J. Ethnopharmacol. 194:83-90. https://doi.org/10.1016/j.jep.2016.08.039
- Hou J, Xue J, Lee M, Liu L, Zhang D, Sun M, Zheng Y, Sung C. 2013. Ginsenoside Rh2 improves learning and memory in mice. J. Med. Food 16:772-776. https://doi.org/10.1089/jmf.2012.2564
- Jin S, Jeon JH, Lee S, Kang WY, Seong SJ, Yoon YR, Choi MK, Song IS. 2019. Detection of 13 ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, compound K, 20(S)-protopanaxadiol, and 20(S)-protopanaxatriol) in human plasma and application of the analytical method to human pharmacokinetic studies following two week-repeated administration of red ginseng extract. Molecules 24:2618.
- Kim DH. 2018. Gut microbiota-mediated pharmacokinetics of ginseng saponins. J. Ginseng Res. 42:255-263. https://doi.org/10.1016/j.jgr.2017.04.011
- Kim JH and Choi JS. 2016. Effect of ginsenoside Rh-2 via activation of caspase-3 and Bcl-2-insensitive pathway in ovarian cancer cells. Physiol. Res. 65:1031-1037. https://doi.org/10.33549/physiolres.933367
- Kim SH, Jung NH, Oh MG, Yoon JT. 2020. Study on the VEGF gene expression and the role of PMSG hormone in the development of endometrial cancer in mice. J. Anim. Reprod. Biotechnol. 35:35-41. https://doi.org/10.12750/JARB.35.1.35
- Lee H, Lee S, Jeong D, Kim SJ. 2018. Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cells. J. Ginseng Res. 42:455-462. https://doi.org/10.1016/j.jgr.2017.05.003
- Li H, Huang N, Zhu W, Wu J, Yang X, Teng W, Tian J, Fang Z, Luo Y, Chen M, Li Y. 2018. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2. BMC Cancer 18:579.
- Lim WT. 2011. Development of biotransformation technique for the production of single minor ginsenoside and bioconversion of medicinal herbs' saponins using the recombinant ginsenosidase clone libraries. Korea Advanced Institute of Science and Technology. https://scienceon.kisti.re.kr/commons/util/originalView.do?cn=TRKO201200002445&dbt=TRKO&rn=
- Ministry of Health and Welfare of South Korea. 2021. Cancer survival rate increased to 70.7%, and the incidence of breast cancer and prostate cancer is on the rise. press release. 2021-12-29. http://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&CONT_SEQ=369164&page=1
- Park H. 2019. The role of gut microbiota in ginsenoside metab-olism and biotransformation of ginsenoside by lactic acid bacteria. Curr. Top. Lact. Acid Bact. Probiotics 5:1-12. https://doi.org/10.35732/ctlabp.2019.5.1.1
- Peng K, Luo T, Li J, Huang J, Dong Z, Liu J, Pi C, Zou Z, Gu Q, Liu O, Zhang JT, Luo ZY. 2022. Ginsenoside Rh2 inhibits breast cancer cell growth via ERβ-TNFα pathway. Acta Biochim. Biophys. Sin. (Shanghai) 54:647-656. https://doi.org/10.3724/abbs.2022039
- Qian J, Li J, Jia JG, Jin X, Yu DJ, Guo CX, Xie B, Qian LY. 2016. Ginsenoside-Rh2 inhibits proliferation and induces apoptosis of human gastric cancer SGC-7901 side population cells. Asian Pac. J. Cancer Prev. 17:1817-1821. https://doi.org/10.7314/APJCP.2016.17.4.1817
- Qian Y, Huang R, Li S, Xie R, Qian B, Zhang Z, Li L, Wang B, Tian C, Yang J, Xiang M. 2019. Ginsenoside Rh2 reverses cyclophosphamide-induced immune deficiency by regulating fatty acid metabolism. J. Leukoc. Biol. 106:1089-1100. https://doi.org/10.1002/JLB.2A0419-117R
- Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J, Cho JY. 2021. Pharmacological potential of ginseng and its major component ginsenosides. J. Ginseng Res. 45:199-210. https://doi.org/10.1016/j.jgr.2020.02.004
- Shi X, Yang J, Wei G. 2018. Ginsenoside 20(S)-Rh2 exerts anticancer activity through the Akt/GSK3β signaling pathway in human cervical cancer cells. Mol. Med. Rep. 17:4811-4816.
- Tang XP, Tang GD, Fang CY, Liang ZH, Zhang LY. 2013. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J. Gastroenterol. 19:1582-1592. https://doi.org/10.3748/wjg.v19.i10.1582
- Tong-Lin Wu T, Tong YC, Chen IH, Niu HS, Li Y, Cheng JT. 2018. Induction of apoptosis in prostate cancer by ginsenoside Rh2. Oncotarget 9:11109-11118. https://doi.org/10.18632/oncotarget.24326
- Xia T, Wang YN, Zhou CX, Wu LM, Liu Y, Zeng QH, Zhang XL, Yao JH, Wang M, Fang JP. 2017. Ginsenoside Rh2 and Rg3 inhibit cell proliferation and induce apoptosis by increasing mitochondrial reactive oxygen species in human leukemia Jurkat cells. Mol. Med. Rep. 15:3591-3598. https://doi.org/10.3892/mmr.2017.6459
- Yang J, Yuan D, Xing T, Su H, Zhang S, Wen J, Bai Q, Dang D. 2016. Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinase. J. Ginseng Res. 40:400-408. https://doi.org/10.1016/j.jgr.2016.03.007
- Yang Y, Liu X, Li S, Chen Y, Zhao Y, Wei Y, Qiu Y, Liu Y, Zhou Z, Han J, Wu G, Ding Q. 2020. Genome-scale CRISPR screening for potential targets of ginsenoside compound K. Cell Death Dis. 11:39.
- Zhang H, Park S, Huang H, Kim E, Yi J, Choi SK, Ryoo Z, Kim M. 2021. Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review). Oncol. Rep. 45:33.